Chargement en cours...
Determination of maximum tolerated dose and toxicity of Inauhzin in mice
Reactivating the tumor suppressor p53 offers an attractive strategy for developing cancer therapy. We recently identified Inauhzin (INZ) as a novel non-genotoxic p53-activating compound. To develop INZ into a clinically applicable anticancer drug, we have initiated preclinical toxicity studies. Here...
Enregistré dans:
| Publié dans: | Toxicol Rep |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4497815/ https://ncbi.nlm.nih.gov/pubmed/26167454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.toxrep.2015.02.011 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|